4//SEC Filing
Hall Steven Edward 4
Accession 0000899243-21-024431
CIK 0001815442other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 4:43 PM ET
Size
5.4 KB
Accession
0000899243-21-024431
Insider Transaction Report
Form 4
Hall Steven Edward
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-06-16+20,063→ 20,063 totalExercise: $49.10Exp: 2031-06-15→ Common Stock (20,063 underlying)
Footnotes (1)
- [F1]The shares underlying this stock option shall vest in full upon the earlier to occur of (i) June 16, 2022 and (ii) the date of the next annual meeting of the Issuer's stockholders.
Documents
Issuer
Kymera Therapeutics, Inc.
CIK 0001815442
Entity typeother
Related Parties
1- filerCIK 0001602732
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 4:43 PM ET
- Size
- 5.4 KB